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The long-term reliability of neural interfaces and stability of high-quality recordings are
still unsolved issues in neuroscience research. High surface area PEDOT-PSS-CNT
composites are able to greatly improve the performance of recording and stimulation
for traditional intracortical metal microelectrodes by decreasing their impedance and
increasing their charge transfer capability. This enhancement significantly reduces the
size of the implantable device though preserving excellent electrical performances.
On the other hand, the presence of nanomaterials often rises concerns regarding
possible health hazards, especially when considering a clinical application of the devices.
For this reason, we decided to explore the problem from a new perspective by
designing and testing an innovative device based on nanostructuredmicrospheres grown
on a thin tether, integrating PEDOT-PSS-CNT nanocomposites with a soft synthetic
permanent biocompatible hydrogel. The pHEMA hydrogel preserves the electrochemical
performance and high quality recording ability of PEDOT-PSS-CNT coated devices,
reduces the mechanical mismatch between soft brain tissue and stiff devices and also
avoids direct contact between the neural tissue and the nanocomposite, by acting as a
biocompatible protective barrier against potential nanomaterial detachment. Moreover,
the spherical shape of the electrode together with the surface area increase provided by
the nanocomposite deposited on it, maximize the electrical contact and may improve
recording stability over time. These results have a good potential to contribute to fulfill
the grand challenge of obtaining stable neural interfaces for long-term applications.
Keywords: carbon nanotubes, PEDOT, pHEMA, microelectrode, neural recordings, biocompatibility
INTRODUCTION
The stability of the interface between neural tissue and chronically implanted microelectrodes is
crucial for recording and stimulation, both for research and clinical purposes, such as localization
and prediction of epileptic seizures, control of pathological neural activity in Parkinson’s disease,
treatment of motor and sensory impairments (Xindong et al., 1999; Polikov et al., 2005;
Hatsopoulos and Donoghue, 2009). Unfortunately, despite the strong efforts of researchers in this
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direction, a stable long-term bidirectional access to brain cells still
remains a challenge.
Many events that occur when the electrode is inserted in the
brain play a role in the failure of the implant. The main enemy
of chronic implants is the gliosis, which is the final result of acute
and chronic tissue reactions that take place around the implanted
device. Micro-motions of the brain around the implanted
electrode produce injuries that keep active the inflammatory
response which leads to the subsequent formation of a glial scar
(Agorelius et al., 2015). The presence of the scar tissue around the
electrode impairs both signal recording and neural stimulation,
displacing surrounding neurons and electrically insulating the
electrode from the neighboring brain regions (Polikov et al.,
2005; Marin and Fernández, 2010). Moreover, the insertion of
the electrode into the brain triggers oxidative stress events at
the device-tissue interface which directly impact on the survival
of both electrode and neurons. Chemical redox reactions that
occur on the surface of the electrode corrode the metal of the
probe and the formation and release of oxygen reactive species
from cell bodies are toxic causing neuron death (Potter-Baker
and Capadona, 2015).
A variety of strategies for minimizing these adverse tissue
reactions have been followed. Among them, the delivery
of bioactive molecules during or after implant (Zhong and
Bellamkonda, 2007; Jhaveri et al., 2009; Mercanzini et al., 2010;
Yue et al., 2013), the electrode miniaturization in conjunction
with the use of high surface area nanomaterial coatings that
increase their recording and stimulation performances (Abidian
and Martin, 2008; Kotov et al., 2009; Castagnola et al., 2010,
2013, 2014a; Castagnola V. et al., 2014; Kim et al., 2010; Kozai
et al., 2012; Depan and Misra, 2014; Kolarcik et al., 2015),
the use of hydrogel coatings or flexible substrates in order to
reduce the stiffness mismatch between the implanted device and
tissue (Polikov et al., 2005; Lind et al., 2010; Aregueta-Robles
et al., 2014; Castagnola et al., 2014b; Castagnola V. et al., 2014;
Agorelius et al., 2015; Khodagholy et al., 2015; Kozai et al., 2015).
In this work, we show that it is possible to combine several
of these techniques for the development of a neural interface
that may lead to an improved compatibility with the neural
tissue. The starting point is a device based on a gold microsphere
grown on the tip of a thin insulated platinum wire, coated with a
nanostructured PEDOT-PSS-CNT composite (Castagnola et al.,
2014b, 2015). This device already benefits from properties that
can potentially minimize adverse tissue reactions: its spherical
shape should help in keeping it in place reducing the compression
forces exerted by the tissue, the thin tether between microprobe
and external connection to the recording/stimulation system
is able to accommodate relative movements of the brain with
respect to the skull, and finally, the PEDOT-PSS-CNT coating
ensures a very low impedance and high charge transfer capability.
In this paper, we have added a further step encapsulating
the microprobe with a soft synthetic permanent biocompatible
hydrogel, Poly(2-hydroxyethyl methacrylate) (pHEMA), while
fully preserving the properties of the nanostructured PEDOT-
PSS-CNT electrode.
The pHEMA hydrogel encapsulation has the purpose to
avoid a direct contact of nanomaterials with the brain tissue
and to act as a physical barrier to their possible detachment.
Furthermore, thanks to its softness, it helps in reducing the
mechanical stiffness mismatch between electrode and cerebral
tissue. Compared to fibrin hydrogel coatings previously used by
our group (Castagnola et al., 2013; De Faveri et al., 2014) that are
fully reabsorbed by the surrounding tissue within 14 days after
the implant, the use of pHEMA allows to considerably increase
the time span of its action. In this work, experiments have been
performed on gold microspheres having diameters similar to
those used in our previous work (Castagnola et al., 2015), but
grown at the end of Pt wires with larger diameter (i.e., 50 µm)
in order to facilitate manipulation during insertion. This work
is indeed focused on the local reaction to various coatings and
not on the rigidity of the conductor, a factor that may affect scar
induction, that will require further studies, but that was here kept
constant by always using the same type of wire. After preparation
of the microprobes, we tested their ability to acquire high quality
single unit recordings during both acute and chronic in vivo
implants in the rat brain through signal to noise ratio evaluation.
To monitor the evolution of the interface between electrode and
tissue during chronic implants, a correlation between recording
quality and in vivo electrochemical properties was carried out.
Scanning electron microscopy imaging and energy dispersive
spectroscopy of explanted microelectrodes were used to assess
the stability of pHEMA coating after implants having a duration
which varied from a few hours to 4 weeks.
MATERIALS AND METHODS
Microprobe Realization and Testing
Implantable Gold Microspheres
Microspheres of fuzzy gold are directly grown by electrochemical
deposition at the end of a 50 µm diameter platinum core wire
insulated by a 10 µm thick polyimide layer (Good Fellow,
England), starting from a 10 mM potassium dicyanoaurate
(I) (Aldrich Chemistry, Sigma Aldrich, USA) agar gel (0.1
wt%) (Fluka Biochemika, Spain), and applying monophasic
voltage pulses (0.2–1.0 V, 240 s, duty cycle 50%) for 9 h using
a potentiostat/galvanostat (PARSTAT 2273, Princeton Applied
Research, USA). The temperature of the gel was kept at 45◦C.
PEDOT-PSS-CNT Electrochemical Co-Deposition
Poly(3,4-ethylenedioxythiophene)(PEDOT) and carboxylated
MWCNTs (COOH-CNTs, NC 3151, < 4 % of COOH
functional groups, Nanocyl S.A., Belgium) nanocomposites
(PEDOT-CNT) were co-electrodeposited from a 0.5 M 3,4-
ethylenedioxythiophene (EDOT, Sigma-Aldrich, USA) aqueous
solution containing 1 mg/ml of suspended COOH-CNTs and
0.6 wt% of poly(sodium 4-styrenesulfonate)(PSS, Sigma-Aldrich,
USA). COOH-CNTs were suspended in ultrapure water (Milli-Q,
Millipore, USA) by horn sonication (Vibra-Cell VCX130, Sonics
and Materials, USA) (6 s at 66% duty cycle pulses, 4 W/ml) for
30 min while keeping the solution cooled with an ice bath. PSS
and the monomer were added to the suspension immediately
afterwards, and the solution was kept deoxygenated by bubbling
nitrogen. The electrochemical deposition was carried out in
inert atmosphere in potentiostatic mode at constant temperature
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(ice bath, 0◦C), using a polymerization potential of 0.8 V vs.
reference electrode for 100 s. Depositions were carried out using
a potentiostat/galvanostat (PARSTAT 2273, Princeton Applied
Research, USA) connected to a three-electrode electrochemical
cell with a platinum counter electrode and an Ag/AgCl reference
electrode.
pHEMA Hydrogel Coating
Poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogel was
polymerized directly on the PEDOT-PSS-CNT coating after a
single dipping into a prepolymer aqueous solution containing
62.5% (w/w) 2-hydroxyethyl methacrylate (HEMA), 0.003%
(w/w) ethylene glycol dimethacrylate (EDGMA) and 0.04%
(w/w) Irgacure 651 (all from Aldrich Chemistry, Sigma Aldrich,
USA). Polymerization was obtained by exposure to UV light
(365 nm, 350 µW/cm2) for 2 h (ENF-260C/FE, Spectroline,
Spectronics Corporation, USA). For optical microscopy, the
pHEMA precursor solution was stained using Ponceau Xylidine
dye (Chroma, Germany).
Optical and Surface Characterization of Coated
Microelectrodes
Gold, PEDOT-PSS-CNT and pHEMA coatings where routinely
examined via optical microscopy using a Leica Zoom APO
16 equipped with a Leica DFC290 digital camera (Leica
Microsystems, Germany). Morphology prior and after brain
implant was studied through scanning electron microscopy
(SEM) using a JEOL JSM-6490LA SEM (JEOL, Japan) and a
Zeiss EVO 40 SEM (Zeiss, Germany). High resolution imaging
of PEDOT-PSS-CNT coated devices was performed using a Jeol
JSM-7500FA FEG SEM. Surface composition of devices was
assessed by energy dispersive spectroscopy (EDS) using a INCA
300 (Oxford Instruments, England) mounted on the Zeiss EVO
40 SEM.
Electrochemical Characterization
The electrochemical behavior of the microelectrodes was studied
in a 0.9% NaCl aqueous solution, by cyclic voltammetry (CV)
to quantify their capacitive charging, and by electrochemical
impedance spectroscopy (EIS) to determine the electrical
properties of the system over a large range of frequencies.
During the CV tests, the working electrode potential was swept
between 0.6 and −1 V vs. Ag/AgCl, maintaining a scan rate
of 100 mV/s. During the EIS measurements, a sine wave (10
mV RMS amplitude) was superimposed onto the open circuit
potential while varying the frequency from 1 to 105 Hz. EIS and
CV were carried out using a potentiostat/galvanostat (Reference
600, Gamry Instruments, USA) connected to a three-electrode
electrochemical cell with a platinum counter electrode and a
Ag/AgCl reference electrode.
Mechanical Measurements
The mechanical response of the pHEMA hydrogel was
characterized through uniaxial compression tests on 10 mm
diameter, 5 mm thick samples. Tests were performed on a dual
column universal testing machine (Instron 3365, USA) under a
displacement rate of 1 mm/min. The Young’s modulus E was
calculated from the initial linear slope of the stress-strain curve.
Seven repetitions were performed.
In vivo Testing And Histology
Animals
Seventeen adult male Wistar rats weighing 250–270 g were used:
six for acute recordings and eleven for chronic experiments.
Details are reported in Table 1. All experimental subjects were
bred in the breeding facility of the University of Ferrara. The
experiments were carried out in accordance with the guidelines
established by the European Communities Council (Directive
2010/63/EU of September 22nd, 2010) and the protocol was
approved by the Italian Ministry of Health (Legislative decree n.
26 of March 2014), authorization n◦ 332/2015-PR.
Animal Surgery for Signal Recording
Wistar rats were anesthetized with a mixture of Zoletil (Virbac,
France; 30 mg/kg) and Xylazine (Bayer, Germany; 5 mg/kg)
administered intraperitoneally (i.p.). For the duration of the
whole procedure, the depth of anesthesia was monitored by
testing the absence of hind limb withdrawal reflex and was
maintained by additional i.m. doses of anesthetic. The body
temperature was maintained at 37–38◦C with a thermostatically
controlled heating pad and lacrigel (Farmigea, Italy) was placed
on eyes to avoid dryness. After shaving and swabbing the head
with ethanol, the anesthetized animal was placed in a stereotaxic
apparatus (David Kopf Instruments, USA) equipped with Ear
Bars (Model 957 for small animals). An approximately 2 cm
long incision was made along the midline of the cranium. The
underlying muscle and connective tissue were retracted to expose
the skull. A craniotomy (5 × 5 mm) was made in the parietal
bone to expose the somatosensory cortex identified according
to vascular landmarks and stereotaxic coordinates (Hall and
Lindholm, 1974; Chapin and Lin, 1984; Paxinos and Watson,
2007). Sterile saline solution was applied while drilling to avoid
any local heating and to keep clean the bone surface.
The exposed dura mater was wetted with saline and
carefully incised using surgical micro-scissors and the tip of
a 24 G syringe needle to producing an opening both in
TABLE 1 | Number of animals and probes used during acute experiments
and chronic implants.
Acute experiments
Animals Recording
positions
PEDOT-
PSS-CNT
pHEMA-encapsulated
6 20 6 6
Chronic implants
Duration Animals Hemispheres PEDOT-
PSS-CNT
pHEMA-encapsulated
14 days 8 16 16 16
28 days 3 4 6 6
It is specified the number of recording positions for acute experiments and the total
number of hemispheres implanted in chronic experiments.
Frontiers in Neuroscience | www.frontiersin.org 3 April 2016 | Volume 10 | Article 151
Castagnola et al. pHEMA Encapsulated PEDOT-PSS-CNT Microsphere Microelectrodes
the dura and in the pia mater. For acute recording sessions,
microsphere electrodes were lowered into the cortex and 35
min of the spontaneous activity was recorded. For each rat,
several traces for the two types of microelectrodes (PEDOT-
PSS-CNTmicrospheres and pHEMA-encapsulated PEDOT-PSS-
CNT microspheres) were recorded from different points of the
cortex, at antero-posterior coordinates comprised between −1.5
and −4.5 mm and medio-lateral coordinates comprised between
2.5 and 4.5 mm. At the end of the recording sessions,
the placement of electrodes was confirmed by histological
section.
Microelectrode Chronic Implantation
For the chronic recordings, a custom-made support holding
two microsphere microelectrodes spaced 1 mm apart was used.
For each experiment, one PEDOT-PSS-CNT microsphere and
one pHEMA encapsulated PEDOT-PSS-CNT microsphere were
implanted in the parietal cortex of both hemispheres. The dura
and pia mater were incised with a needle and the microelectrodes
were manually advanced into the cortex. After implant, the
surface of the implanted tissue was protected using Kwik-
Sil silicone polymer (World Precision Instruments Inc, USA)
and both supports, excluding the connector, were cemented to
the skull using dental acrylic (Jet Repair Acrylic; Lang Dental
Manufacturing, USA). To hold in place the dental acrylic, four
stainless steel bone screws were inserted into the skull and a
stainless steel ground wire was attached to the nearest screw as a
reference. The skin was sutured around the cement, gentamycin
cream (Mylan s.p.a., Italy) was spread over the wound and finally
an antibiotic solution of Baytril 5% was administered (Bayer,
Germany, 0.5 ml/10 kg, i.m.).
Neural Recordings
Neural recordings from the somatosensory cortex were
performed to characterize the electrical performance of the
microelectrodes in vivo. Electrophysiological data were acquired
using TDT RZ-2 Processor and PZ2 preamplifier (Tucker-Davis
Technologies, USA). The gain was set to 1. The acquired neural
traces were sampled at 24,414 Hz and bandpass filtered from 10
to 5000 Hz. To connect the microelectrodes to the headstage, a
custom support for ZIF-Clip (Tucker-Davis Technologies, USA)
was designed. Recorded data were stored and analyzed off-line
using the Off-Line Sorter software (Plexon Inc, USA). In chronic
recordings, data were acquired at day 1, 7, 14, 21, and 28 after the
implant.
Histology and Immunofluorescence
At the end of the recording sessions, the animals weremaintained
deeply anesthetized and transcardially perfused with 300 ml
of 0.9% saline solution at room temperature followed by 500
ml cold fixative solution of 2.0% paraformaldehyde, 1.25%
glutaraldehyde and 2.0% sucrose (all from VWR, USA), prepared
in 500 ml of 0.1 M sodium phosphate buffered solution (PBS,
pH, 7.4). Brains were then removed, postfixed overnight at 4◦C
and placed in a 30% sucrose-buffered solution until they sank.
They were then frozen and 50 µm-thick coronal sections were
cut using a sliding microtome (SM2000R; Leica Microsystems,
Canada).
To determine the (localization) layer of the recording,
the sections belonging to the rats of acute session were
stained with thionin (Sigma Aldrich, USA) and viewed
under brightfield illumination with an Olympus BX51
microscope (Olympus, USA) coupled with a color video
camera CX-9000 (MicroBrightField, USA) and with the
NeuroLucida system (MicroBrightField, USA). Thionin-stained
sections containing the electrode traces were acquired at 125×
magnification (see Supplementary Figure 6S).
In order to investigate the tissue response to electrode
implant the immunofluorescence staining was performed at
2 weeks (1 rat, 2 hemispheres, 2 PEDOT-PSS-CNT and 2
pHEMA-encapsulated microspheres) and 4 weeks (2 rats, 3
hemispheres 4 PEDOT-PSS-CNT and 4 pHEMA-encapsulated
microspheres) after implant. The brain sections were stained
using antibodies directed against reactive astrocytes detected
by the production of glial fibrillary acidic protein (GFAP);
activated microglia/macrophages detected by the membrane-
bound CD68-antigen (clone-ED1); neuronal nuclei (NeuN) and
total number of cell nuclei (DAPI), to label the principal cell lines
involved in the inflammatory tissue reaction.
The adjacent sections were divided into two series, treated
with blocking solution consisting of 4% (v/v) normal goat serum
(Sigma Aldrich, USA), 0.5% (v/v) Triton-X-100 (Sigma Aldrich,
USA), 2% (w/v) bovine serum albumin (BSA) (Sigma Aldrich,
USA) in PBS for 1 h and then incubated in the primary antibodies
overnight at room temperature. The first series was stained using
mouse-anti-GFAP (1:500, Sigma Aldrich, USA) and rabbit-anti-
NeuN (1:200,Millipore, USA) while the second one usingmouse-
anti-ED1 (1:300, Millipore, USA). After 3 rinses in PBS (10 min
per rinse) the sections were incubated with the antirabbit-Alexa-
488 and antimouse-Alexa-633conjugated secondary antibodies
(1:500, Thermo Fisher Scientific, USA) for 4 h in the dark, at
room temperature. All mentioned antibodies were used diluted
in the blocking solution. Finally, after washing 3 times in PBS,
the two series sections were mounted separately onto microscope
slides, counterstained with ProLong R© Gold Antifade Mountant
containing DAPI (Thermo Fisher Scientific, USA) and covered
with a coverglass. For the different antibody protocols, controls
by omission of primary antibodies were negative.
The staining was observed using an BX51 microscope with
10×, 20×, 40× objectives (Olympus, Japan) and equipped
with a X-Cite R© 120 fluorescence microscopy illumination
system (EXFO, Canada) and a color video camera CX-9000
(MicroBrightField, USA). The images of the fluorescence of the
ED1-positive cells (red), GFAP-positive cells (red), neuron nuclei
(green) and cell nuclei (blue) were acquired and analyzed using
NeuroLucida (MicroBrightField, USA) and ImageJ software
(developed at the National Institutes of Health, USA).
In vivo Impedance Measurements
The in vivo impedances of chronic implanted microspheres
were analyzed through electrochemical impedance spectroscopy
(EIS) using the two-electrode configuration. The implanted
microspheres were referenced to a low impedance stainless steel
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bone screw inserted into the skull (see Section Microelectrode
Chronic Implantation). The two-electrode method is suitable
for measuring impedance from microelectrodes due to the large
difference in impedance relative to the reference and the small
current that passes through the circuit (Brett and Brett, 1993;
Williams et al., 2007). During the EIS measurements, a sine wave
(10 mV RMS amplitude) was imposed onto the open circuit
potential while varying the frequency from 1 to 105 Hz. EIS
were carried out using a potentiostat/galvanostat (Reference 600,
Gamry Instruments, USA). Impedance spectra measurements
were repeated three times for each microelectrode at day 1, 7, 14,
21, and 28 after the implant.
Evaluation of Signal-To-Noise Ratio
To evaluate the signal-to-noise ratio (SNR), each acquired trace
was digitally high-pass filtered above 300 Hz (Butterworth, 4-
poles). The signal was wavelet decomposed and thresholded
to 4.5 standard deviations (SD) above and below the mean
of the sample distribution to discriminate signal from noise.
Waveforms were clustered using T-Distribution E-M Algorithm.
This algorithm is a variant of the E-M algorithm by Shoham
et al. (Figueiredo and Jain, 2003; Shoham et al., 2003), fits the
available data points by adopting T distributions and provides
a robust alternative to the use of gaussian mixture models,
automatically down-weighting the effect of outlier waveforms.
It starts by processing a large number of clusters and combines
them together as the algorithm proceeds, so as to minimize a
penalized likelihood function (Shoham et al., 2003). All the spikes
with inter-spike-interval (ISI) smaller than the refractory period
(2 ms) have been removed.
In the present article the method adopted to evaluate the SNR
is based on computing the median of the distribution of the
absolute value of the signal. The method is introduced by Dolan
et al. (Dolan et al., 2009). Briefly, for Gaussian noise, the median
of the absolute value of the signal will be 0.6745σn, where σn is the
standard deviation of the Gaussian noise. Therefore, the standard
deviation of the noise can be estimated as follows:
σn = median
∣
∣x(t)
∣
∣
0.6745
(1)
where x(t) is the original recorded signal.
Finally, the SNR was calculated as follows:
SNR =
S
(2σn)
(2)
where S is the signal amplitude defined as the peak-to-peak
amplitude of the mean waveform for each cluster and the noise
was defined as two times the estimated standard deviation of the
noise.
The statistical significance between the average SNR,
calculated for both type of microspheres, was assessed by a
one-way ANOVA (p < 0.05 significance level). Values were
expressed as mean± Standard Error of Mean (SEM).
Signal Power Calculation
The signal was estimated by computing the spectral power
densities (SPDs, data sampling rate 24,414 Hz, segmentation
length of 512, zero-overlapping ratio of the segments, 2–5000
Hz window function) of unfiltered spike activities recorded using
PEDOT-PSS-CNT and pHEMA-encapsulated microspheres. The
signal spectral power over the spike frequency range was
computed as the integral of the SPDs of the signals between 250
and 3000 Hz, the frequency range were individual spikes can be
detected.
RESULTS
Electrochemical and Physical Properties of
Microprobes
Electrochemical Properties of PEDOT-PSS-CNT
Coated Microspheres
Coating the gold microspheres, that had a diameter in the
range of 100 µm (106.5 ± 9.3 µm, N = 10) with PEDOT-
PSS-CNT significantly reduces their impedance, as shown by
the impedance spectra reported in Figure 1A. The impedance
values of pristine gold microspheres are 3.96 ± 0.95 k at 1
kHz, 13.04 ± 3.07 k at 100 Hz and 324.04 ± 100.37 k at 1
Hz (mean ± standard deviation, 10 samples), much lower than
commercially available intracortical microelectrodes, i.e., quartz
insulated platinum/tungsten tips (Ansaldo et al., 2011). PEDOT-
PSS-CNT coating further decreases the impedance in all the
frequency range, and especially in the low frequency band (1.04±
0.17 k at 1 kHz, 1.24± 0.24 at 100 Hz and 9.56± 4.13 at 1 Hz).
A second effect of PEDOT-PSS-CNT coating is the large increase
in charge transfer capability (CTC), calculated as the time integral
of an entire CV cycle between 0.6 and −1V, that passes from
101.6 ± 64.4 mC/cm2 of the pristine gold microspheres to
540.7 ± 70.3 mC/cm2 of the PEDOT-PSS-CNT coated ones.
An example of CVs of pristine and PEDOT-PSS-CNT coated
microspheres is shown in Figure 1B.
SEM images of a platinum wire at beginning of the process
(Figures 2A,B) aftermicrosphere growth (Figure 2C,E) and after
PEDOT-PSS-CNT coating (Figure 2D) are reported. Higher
resolution imaging of PEDOT-PSS-CNT coated microspheres
obtained with scanning electron microscopes having different
performance, (Figure 2F) and (Figures 2G,H), shows the
emergence of the fine nanoscale CNT scaffold structure,
similar to what already demonstrated on flat electrode surfaces
(Castagnola et al., 2013).
Electrochemical Properties after pHEMA
Encapsulation of PEDOT-PSS-CNT Microspheres
Two fundamental reasons lead us to encapsulate the PEDOT-
PSS-CNTmicrospheres with pHEMAhydrogel. The first one was
to enable a safe use of nanomaterials otherwise in direct contact
with brain tissues (aiming at their use on human subjects) and
the second was to reduce the mechanical mismatch in stiffness
between electrode and cerebral tissue. As shown in Figure 3A, the
pHEMA hydrogel evenly coats and encapsulates the microsphere
and supporting wire, as also confirmed by optical imaging
of dyed pHEMA (Supplementary Figure 1S). The pHEMA
encapsulation preserves the electrochemical performance of
PEDOT-PSS-CNT microspheres, as impedance and CTC values
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FIGURE 1 | (A) Impedance spectra of commercial microelectrodes (black),
gold microspheres before (blue) and after (red) PEDOT-PSS-CNT
electrodeposition and (green) PEDOT-PSS-CNT coated microspheres after
pHEMA encapsulation. (B) Sample cyclic voltammograms of a gold
microsphere (blue) and a PEDOT-PSS-CNT coated microsphere before (green)
and after (red) pHEMA encapsulation.
were maintained within the standard deviation value of non-
encapsulated microprobes (1.2 ± 0.5 k at 1 kHz, Figure 1A).
Finally, we found that the pHEMA-encapsulated microelectrodes
withstand the sterilization process in the absence of significant
changes in impedance values (0.9 ± 0.6 k @ 1 kHz before and
1.2± 0.9 k @ 1 kHz after sterilization).
Sturdiness and Electrochemical Stability of pHEMA
Encapsulation
To perform in-vitro tests for evaluating the stability of pHEMA
encapsulation, we have immersed pHEMA coated microspheres
in a phosphate buffered saline (PBS) solution containing 30
mM of H2O2 for 1 week, mimicking the situation where the
device is implanted in the human body and hydrogen peroxide
is generated by an inflammatory reaction (Fonseca and Barbosa,
2001; Patrick et al., 2011). The pHEMA encapsulation showed to
withstand the test without visible erosion or cracks. An image of
the same pHEMA-encapsulated PEDOT-PSS-CNT probe before
and after the immersion test is shown in Figures 4A,B.
To evaluate the ability of the pHEMA-encapsulated PEDOT-
PSS-CNT microspheres to withstand the mechanical stress
of brain implants, we investigated their morphology, surface
composition and electrochemical properties after implanting
FIGURE 2 | Representative SEM images of (A,B) platinum wire before
deposition (lateral and frontal view), (C) gold microsphere, and (D)
PEDOT-PSS-CNT coated microsphere. Higher magnification images of the
surface morphology of (E) nanostructured gold and of (F) PEDOT-PSS-CNT
composite obtained by Zeiss EVO 40 SEM. High resolution images of (G,H)
PEDOT-PSS-CNT composite obtained by Jeol JSM-7500FA FEG-SEM.
them in the cerebral cortex of anesthetized animals to record the
neural activity. Figures 5A,B shows an example of SEM image
of the pHEMA-encapsulated PEDOT-PSS-CNT microsphere
that was previously implanted in rat cortex. One can notice
that the main visible consequence is the mere accumulation
of tissue debris and erythrocytes on the hydrogel surface
that are easily recognizable in the inset of Figure 5A. We
have acquired SEM images at the same magnification of
the hydrogel surface (Figure 5B) and of a non–encapsulated
PEDOT-PSS-CNT microsphere (Figure 5C). Non–encapsulated
PEDOT-PSS-CNT microsphere maintains, after the insertion
and recording in rat brain, the typically rough and porous
surface of the non-coated probe. Conversely, the pHEMA-
encapsulated PEDOT-PSS-CNT microsphere keeps the smooth
pHEMA surface morphology both before (Figure 3B) and after
(Figure 5B) implant and recording. In order to verify that indeed
pHEMA is still present after probe implant, we have performed
EDS analysis of pHEMA-encapsulated microspheres prior and
after implants, comparing results with spectra obtained from
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FIGURE 3 | Representative SEM micrographs of (A)
pHEMA-encapsulated PEDOT-PSS-CNT microsphere and (B) higher
magnification of the pHEMA coating.
FIGURE 4 | Representative SEM micrographs of the same
pHEMA-encapsulated PEDOT-PSS-CNT microsphere (A) before and (B)
after one week immersion in a PBS solution containing 30 mM of H2O2
to mimick the situation where the device is implanted in the human
body and hydrogen peroxide is generated by an inflammatory reaction.
non-encapsulated PEDOT-PSS-CNT microspheres and from a
reference sample of pHEMA. As we are dealing with a low
density material—the hydrogel and the conductive polymer—
made from low atomic number elements, one has to take into
account that the penetration depth of the electron beam is
several micrometers and can reach the underlying microsphere
surface. Differences in detected composition between the pristine
PEDOT-PSS-CNT devices and the pHEMA encapsulated ones
regard mainly the relative amount of detected carbon, gold and
sulfur. In the case of pristine PEDOT-PSS-CNT microspheres,
one finds a significant sulfur signal that arises from PEDOT-
PSS and also a high gold signal from the underlying gold-ball.
A smaller sodium signal can also be attributed to PEDOT-PSS.
When encapsulated with a pHEMA layer (dry thickness 6.49
± 2.62 µm, average of 10 samples), gold and sulfur percentage
significantly decrease due to the presence of the hydrogel layer
FIGURE 5 | Representative SEM images of (A) a pHEMA encapsulated
PEDOT-PSS-CNT microsphere after recordings in rat and (B) the
higher magnification of the pHEMA surface after recordings in rat. (C)
Magnification of the surface of a PEDOT-PSS-CNT coated microsphere
(without pHEMA) after recordings in rat. (D) Example of magnitude impedance
of a pHEMA encapsulated PEDOT-PSS-CNT coated microsphere before and
after various recording sessions.
that reduces the number of electrons reaching the underlying
materials, while the oxygen and carbon signals have values similar
to those of pure pHEMA (see Supplementary Table 1S and
Supplementary Figure 2S for examples of such spectra). We
have then performed EDS analysis on non-encapsulated PEDOT-
PSS-CNT microspheres and pHEMA-encapsulated probes that
have either been inserted three times in the rat cortex (acute
experiment) or have been implanted for 28 days, comparing
results with the analysis performed on pristine probes (Table 2).
Examples of corresponding spectra are shown in Supplementary
Figures 3S, 4S. Comparing the EDS analysis results for each kind
of microsphere, we find that the characteristic signatures - higher
S and smaller C values for PEDOT-PSS-CNT and the opposite for
pHEMA - and preserved after implant.We also compared images
and EDS spectra for the same pHEMA-encapsulated probes
before and after implant, and an example of results are shown in
the Supplementary Figure 5S. This is an indirect but convincing
proof that both the PEDOT-PSS-CNT coating and the pHEMA
layer withstand implant up to 28 days. Finally, Figure 5D reports
an example of impedance magnitude spectra of a pHEMA-
encapsulated PEDOT-PSS-CNT microsphere before and after
several brain insertions and recording sessions, showing that the
impedance is maintained well below 2 k for frequencies above
10 Hz.
Reduced Mechanical Mismatch between Brain and
pHEMA Encapsulated Electrodes
The Young’s modulus value of the pHEMA hydrogel, calculated
from the initial linear slope of the stress-strain curve, was E =
0.091 ± 0.023 MPa. The lower stiffness of the hydrogel coating
as compared to the naked metal electrode, together with the fact
that the coating makes the radius larger, helps to reduce the
elastic mismatch with cerebral tissue and thus reduces the contact
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TABLE 2 | Relative percentage of chemical elements found by EDS on: PEDOT-PSS-CNT non-encapsulated microspheres before and after acute
implantation (mean values for 4 probes, 4 spectra for each probe, 3 insertions); pHEMA-encapsulated microspheres before and after acute implant
(mean values for 4 probes, 4 spectra for each probe, 3 insertions); a PEDOT-PSS-CNT non-encapsulated microsphere and a pHEMA-encapsulated one
(mean values of 4 spectra each) 28 days after implantation.
O (%weight) C (%weight) S (%weight) Na (%weight) Au (%weight)
PEDOT-PSS-CNT probe before acute implant 77.9 ± 2.8 14.6 ± 3.3 7.2 ± 1.3 0.2 ± 0.2 –
PEDOT-PSS-CNT probe after acute implant 76.7 ± 4.8 14.5 ± 4.6 6.4 ± 1.4 0.20 ± 0.3 1.3 ± 2.7
pHEMA-encapsulated probe before acute implant 67.9 ± 4.8 31.3 ± 5.5 0.7 ± 1.1 – –
pHEMA-encapsulated probe after acute implant 69.6 ± 5.4 29.1 ± 5.9 0.5 ± 1.2 0.04 ± 0.1 0.6 ± 1.7
PEDOT-PSS-CNT probe after 28 days implant 75.9 ± 6.4 14.5 ± 2.9 3.7 ± 3.4 0.2 ± 0.1 5.2 ± 4.9
pHEMA-encapsulated probe after 28 days implant 69.5 ± 3.2 30.3 ± 3.4 0.2 ± 0.3 – –
pressure upon the tissue itself when and if small displacements of
the implanted electrode occur.
The improvement in this direction can be quantified
considering the contact between the electrode tip and the cavity
as two conforming surfaces (Goodman and Keer, 1965). The
pressure-penetration relationship is not trivial, as the exact
conformity, i.e., the (small) clearance between cavity and sphere
is not known. However, evenwithout precise quantification of the
contact pressure, the dependencies on stiffness and sphere size
can be expressed as (Liu et al., 2005):
p0 ∝
E∗
R
(3)
Where E∗ is the reduced modulus:
1
E∗
=
1− ν21
E1
+
1− ν22
E2
(4)
With E and ν the Young’s modulus and Poisson ratio of either
contacting material, identified with subscripts 1 and 2, and d the
center-to-center displacement.
We simulate according to this model the relative displacement
of the implanted electrode to impinge on the surrounding tissue,
already in contact. We consider the relative variation of contact
pressure arising from modifications of the parameters E∗ and R,
for the sake of comparison. We assume also small displacements,
so that we treat each material as a bulk body rather than a coated
system, and Poisson ratio ν = 0.49 for PHEMA, which is the
typical value of hydrogels, due to their very low compressibility.
For cerebral tissue, we take the value E = 0.01 MPa, ν = 0.45
(Soza et al., 2005).
From Equation (3), it can be seen that contact pressure is
proportional to the reduced modulus E∗ and to the sphere radius
to the power of −1. For a given displacement d, the relative
variation of contact pressure with respect to the uncoated system
(gold, E = 79 GPa, Poisson ratio ν = 0.42 , R = 50 µm) is
around 20%. This reduced mechanical mismatch between the
brain and the pHEMA encapsulated probe is expected to have
positive effects by lowering tissue damage.
Results of In vivo Recordings
Acute Recordings
In order to validate the recording capability of pHEMA-
encapsulated microspheres, we analyzed and compared the
neural signals acquired from the parietal cortex of six rats
during acute recording sessions using six non-encapsulated
and six pHEMA-encapsulated PEDOT-PSS-CNT microspheres.
During each recording session, 35-min recording traces were
acquired. To limit the experimental variability, the same cortical
region was recorded, identified on the basis of stereotaxic
coordinates (see Section Animal Surgery for Signal Recording).
To determine the localization of the microelectrodes a thionin
staining was adopted and penetration traces of PEDOT-PSS-
CNT and pHEMA-encapsulated microspheres were examined
(examples of traces are shown in Supplementary Figure 6S).
pHEMA encapsulation did not alter the microspheres capability
to record action potentials from single units. In fact, the average
SNR calculated for pHEMA encapsulated PEDOT-PSS-CNT
microspheres (n = 6) is not significantly different from the value
of SNR calculated for the non-encapsulated PEDOT-PSS-CNT
microspheres (n= 6) [1.74± 0.15 vs. 1.87± 0.26; F(1, 13) = 0.18;
p= 0.67 one-way ANOVA].
Chronic Recordings and Effects on pHEMA
Encapsulation
pHEMA-encapsulated (22 microspheres) and non-encapsulated
PEDOT-PSS-CNT (22microspheres) were chronically implanted
in the parietal cortex of 11 rats (see Table 1 for details).
Afterwards, in vivo impedance spectra and recordings were
acquired weekly, up to 28 days, to evaluate the electrochemical
properties and functional integrity of the encapsulated
microspheres into the brain.
Figure 6 reports high-pass filtered (cut-off 250 Hz) example
traces of 800 ms activity recorded in chronic experiments
with non-encapsulated PEDOT-PSS-CNT (black) and pHEMA-
encapsulated (blue) microspheres at 1, 7, 14, 21, and 28 days
after the implant. In both cases, after the first day post-implant
when the spike amplitude was lower, spiking activity remained
relatively constant from 7 to 28 days after implant. To verify the
spikes recording capability wemeasured the number of spikes per
minute in a range of 1000 s of acquired high-pass filtered data.
The results are reported in Table 3.
The same results are confirmed by the SPDs (Figure 7)
obtained for 10 seconds of the non-filtered spontaneous activity
recorded from the same animal using PEDOT-PSS- non-
encapsulated CNT microspheres (Figure 7A) and pHEMA-
encapsulated (Figure 7B) microspheres at 1, 7, 14, 21, and 28
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FIGURE 6 | High-pass filtered (cut-off 250 Hz) traces (800 ms) recorded
for non-encapsulated PEDOT-PSS-CNT (black) and
pHEMA-encapsulated (blue) microspheres at 1, 7, 14, 21, and 28 days
after the implant.
TABLE 3 | Spikes/min (average ± SD) recorded from 3 animals (4
hemispheres) at 1, 7, 14, 21, and 28 days after implant, and from 6 animals
(12 hemispheres) at 1, 7, and 14 days after implant.
Days after implant non-encapsulated
microspheres
pHEMA encapsulated
microspheres
28 days implants (3 animals, 4 hemispheres)
1 1519.0 ± 523.0 1594.2 ± 467.7
7 1504.5 ± 595.7 1635.0 ± 529.7
14 2492.0 ± 139.6 1863.0 ± 786.7
21 1654.3 ± 1151.4 1313.8 ± 505.4
28 1729.8 ± 948.1 1902.4 ± 697.9
14 days implants (6 animals, 12 hemispheres)
1 1133.0 ± 542.8 1259.0 ± 836.1
7 1189.5 ± 712.0 1249.6 ± 903.7
14 1464.2 ± 879.4 1539.3 ± 867.6
Data of non-encapsulated PEDOT-PSS-CNT and pHEMA-encapsulated PEDOT-PSS-
CNT microspheres are shown.
days after the implant. An example of signal power values over
the spike frequency range, computed as the integral of the SPDs
of the signals between 250 and 3000 Hz -the frequency range
where spikes of individual neurons can be detected- is reported
in Supplementary Table 2S. After 28 days both encapsulated and
non-encapsulated electrodes were still able to record high-quality
spiking activity.
The impedance spectra behavior in the whole frequency range
(1 ÷ 105 Hz), reported in Table 4, is similar for both types
of microelectrodes, with an increase of impedance after the
first day from the implant. The impedance spectra respectively
of non-encapsulated and pHEMA-encapsulated PEDOT-PSS-
CNT 1, 7, 14, 21, and 28 days microspheres from the implant
are shown in Figure 8. These impedance values stay within
the impedance range that allows to efficiently record action
potentials during the whole implant period, as previously shown
(Figures 6, 7). The implanted microspheres, after being removed
from the brain, were analyzed using SEM. This confirmed the
persistence of an intact pHEMA encapsulation and no insulation
delamination. Figures 12A,B shows some examples of high-
magnification SEM images of the surface for non-encapsulated
and pHEMA encapsulated PEDOT-PSS-CNT microspheres,
respectively, after 28 days from the implant. The PEDOT-
PSS-CNT exhibits its typical rough and porous morphology,
while the pHEMA encapsulation maintains its smooth surface
morphology. When EDS analysis (see Section Sturdiness and
Electrochemical Stability of pHEMA Encapsulation and Table 2)
was performed on these samples, we found results similar
to those obtained on pristine samples, indicating that the
pHEMA encapsulation withstands brain insertion and 28 days
implant.
Immunofluorescence
Immunofluorescence analysis was performed on four non-
encapsulated and four pHEMA-encapsulated PEDOT-PSS-CNT
microspheres tracks of three hemispheres at 2 weeks and 4
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FIGURE 7 | SPDs obtained for the non-filtered spontaneous activity recorded from the rat brain using non-encapsulated PEDOT-PSS-CNT (A) and
pHEMA-encapsulated (B) microspheres at 1, 7, 14, 21, and 28 days after the implant.
TABLE 4 | Impedance values at 1 kHz of pHEMA-encapsulated and
non-encapsulated PEDOT-PSS-CNT coated microspheres.
Days after the implant PEDOT-PSS-CNT pHEMA encapsulated
1 9.9± 1.2k 8.8±0.2k
7 14.7± 0.6k 25.6±1.6k
14 34.8± 16.8k 46.9±25.7k
21 54.6± 28.2k 30.8±4.8k
28 26.3± 4.2k 33.2±7.1k
weeks after the implant. The density of GFAP immunoreactivities
surrounding the microsphere tracks was measured with ImageJ
software on images at 8-bit color of 4 tracks acquired using a 20×
lens. The quantification box that delimited the region of interest
was chosen considering the extension of the reactive glia near the
track and the same box in the same slice was used to measure the
background values captured distant from the track. The density
values of background was subtracted from the density of GFAP
fluorescence.
In the 2-weeks implanted animals the levels of GFAP for
both non-encapsulated and pHEMA encapsulated PEDOT-PSS-
CNTmicrospheres (Figures 9A,B) were similar, with 43.84% and
42.91% of intensity compared to the background, respectively.
The activated astrocytes presented the same extension in
surrounding tracks for both type of microelectrodes (28–135 µm
for non-encapsulated and 29–141 µm encapsulated ones). After
4 weeks of implant GFAP expression (Figures 10A,B) increased
by 28.95%with respect to the background with non-encapsulated
microspheres and by 37.69% with pHEMA-encapsulated ones.
GFAP staining surrounding the tracks was 15–150 µm for
non-encapsulated and 10–100 µm for pHEMA-encapsulated
microspheres.
As shown in Figures 9, 10, at both 2 and 4 post-implant
weeks and for both types of microelectrode, the number of
GFAP stained cell nuclei surrounding the tracks was increased
(Figures 9C,D, 10C,D), but without any detectable neuronal loss
(Figures 9E,F, 10E,F). Few ED1-positive cells were observed at
2 post-implant weeks in proximity of tracks for both type of
microelectrodes (Figures 11A,B), while no evidence of ED1-
positive cells was identified at 4 weeks (Figures 11C,D).
DISCUSSION
The aim of this paper was to combine in a single device
several techniques for improving long-term reliability of
neural interfaces and stability of recordings. These techniques
have been: (1) the use of gold nanostructured microspheres
electrochemically grown at the free end of a thin tether; (2)
the use of high surface area PEDOT-PSS-CNT coatings; (3)
the encapsulation of the PEDOT-PSS-CNT coated microspheres
with a soft, synthetic and permanent biocompatible hydrogel.
The starting point of this work was the systematic use of
the device, presented in our previous studies (Castagnola et al.,
2014b, 2015), made from an electrochemically grown gold sphere
(the recording site) at the free end of a thin insulated platinum
wire. We have here used 50 µm diameter Pt wires with stiffness
of 0.63 N/mm, much thinner and flexible when compared to
a commercial probe with typical stiffness of 13 N/mm (TREC
microelectrodes by Thomas Recording, Germany), and it is
possible to extend the results using the same gold spheres grown
at the end of much thinner wires (e.g., 12 µm diameter platinum
core, Castagnola et al., 2015) thus taking full advantage of
the high flexibility of the tether. Our device is able to better
accommodate motions of the brain with respect to the skull and,
at the same time, has a recording surface sufficient in size to
allow electrochemical properties adequate for both recording and
stimulation experiments. We have shown that it is possible to
reduce the impedance and increase the charge transfer capability
of these microprobes by coating them with a PEDOT-PSS-CNT
high surface area composite (Castagnola et al., 2015). For this
study we produced a very large number of PEDOT-PSS-CNT
coated microspheres, consistently reproducing previous results
for improvement of impedance and charge transfer capability.
The differences in electrical behavior between the microstuctured
gold and the PEDOT-PSS-CNT composite, can be attributed to
two contributions: one coming from the PEDOT:PSS conduction
mechanism and the other from the nanoporous CNT scaffold. In
fact, compared to gold, the conducting polymer (PEDOT:PSS) is
able to conduct both ionic and electronic current, enhancing the
efficiency of signal transduction (Berggren and Richter-Dahlfors,
2007; Abidian and Martin, 2008; Rivnay et al., 2014). The
high capacitance of the material originates from the pseudo-or
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FIGURE 8 | (A) In vivo impedance spectra (magnitude) of non-encapsulated microspheres at 1 (red), 7 (green), 14 (blue), 21(cyan), and 28 (black) days AFTER the
implant. (B) In vivo impedance spectra (magnitude) of pHEMA encapsulated PEDOT-PSS-CNT coated microspheres at 1 (red), 7 (green), 14 (blue), 21(cyan), and 28
(black) days after the implant.
FIGURE 9 | Fluorescence microscopy images of tracks for
non-encapsulated (left panels) and pHEMA-encapsulated (right panels)
microspheres at 2 weeks after implant. (A,B) show the GFAP-positive
cells (red) at 40× to underline the morphology of astrocytes; (C,D) cell nuclei
(blue) merged on GFAP staining to show the density of DAPI surrounding
tracks; (E,F) neuronal nuclei (green) merged with GFAP staining to show the
presence of neuronal bodies surrounding the track.
redox-capacitance of PEDOT (Bard and Faulkner, 2001; Gerwig
et al., 2012). Charge transfer capacitance is then further enhanced
by the nanometer scale porosity of the CNT scaffold, that
increases the surface area of PEDOT:PSS available to the solution
(Gerwig et al., 2012; Samba et al., 2014). In fact, PEDOT-
PSS-CNT is a very promising material for neural interfaces
as, with respect to conventional metal electrodes, shows higher
FIGURE 10 | Fluorescence microscopy images of tracks for
non-encapsulated (left panels) and pHEMA-encapsulated (right panels)
microspheres 4 weeks after implant. (A,B) show the GFAP-positive cells
(red) at 40× to underline the morphology of astrocytes; (C,D) cell nuclei (blue)
superimposed on GFAP staining to verify the density of DAPI surrounding the
tracks; (E,F) neuron nuclei (green) superimposed on GFAP to show the
presence of neuronal bodies surrounding the tracks.
conductivity, better electrochemical stability, greater mechanical
properties and has shown to perform well during in vivo
recordings (Gerwig et al., 2012; Castagnola et al., 2013; Chen
et al., 2013; Kozai et al., 2015; Samba et al., 2015).
The presence of CNTs or other nanomaterials onto the
microelectrodes surface, often rises concerns regarding possible
health hazards, especially when considering a clinical application
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FIGURE 11 | Fluorescence microscopy images of tracks for
non-encapsulated (left panels) and pHEMA-encapsulated (right panels)
microspheres, 2 and 4 weeks after the implant. (A,B) show the
ED1-positive cells (red) at 20× at 2 weeks; (C,D) show the ED1-positive cells
(red) at 20× at 4 weeks.
of the devices (Oberdörster et al., 2005; Resnik and Tinkle,
2007; Sahoo et al., 2007). To prevent this risk, we previously
demonstrated that a fibrin hydrogel encapsulation of high-
density arrays of epicortical microelectrodes is electrically
transparent and can provide a mechanically/chemically stable
barrier that avoids direct exposure of the brain to nanomaterials
while maintaining all the electrical advantages deriving from the
nanostructured electrode surface (Castagnola et al., 2013, 2014b).
However, the fibrin coating of intracortical microelectrodes
implanted in rat brain is almost completely reabsorbed in
a few weeks in vivo (De Faveri et al., 2014), making it
eligible only as a barrier for acute implants. As our aim
was to improve the quality of long-term electrode implants,
we have introduced here the use of the synthetic hydrogel
pHEMA. In general, compared to hydrogels composed of
only natural materials, synthetic hydrogels allow obtaining
a rigorous control of their polymerization, degradation, and
biocompatibility. Furthermore, they are more chemically defined
and biologically inert than those based on natural materials,
decreasing the possibility of immunorejection when implanted
into the brain (Aurand et al., 2012). We have focused our
attention on the pHEMA hydrogel, as it is a widely studied
polymer that has found several biomedical applications, such as
contact lenses, bioadhesive gels for drug delivery applications,
and thrombo-and fibro-resistant coatings (Mohoned et al.,
2005).
The first essential result has been the demonstration
that pHEMA encapsulation of the PEDOT-PSS-CNT coated
microspheres fully preserves the superior electrochemical
performance of high surface areas, while introducing a physical
barrier that reduces the hypothetical risk of a direct contact
of the tissue with the nanomaterials. Moreover, mechanical
measurements have shown that the pHEMA hydrogel coating
reduces by 20% the contact pressure between electrode and
FIGURE 12 | Representative SEM images of (A) PEDOT-PSS-CNT
coated microsphere (without pHEMA) and (B) pHEMA encapsulated
PEDOT-PSS-CNT coated microsphere after 28 days of permanence in
rat brain.
brain tissue, a key factor for the reduction of foreign body
rejection (Polikov et al., 2005; Lind et al., 2010; Aregueta-
Robles et al., 2014; Agorelius et al., 2015; Kozai et al., 2015).
We have also shown that pHEMA-encapsulated microelectrodes
were suitable for in vivo recordings in the rat brain, preserving
the recording quality of the PEDOT-PSS-CNT microspheres
without pHEMA. To validate this result, it was essential to
find out whether the pHEMA encapsulation stays in place
both during acute and chronic implants. We found that
pHEMA withstands the mechanical stress occurring during
several consecutive brain insertions in acute experiments.
Concerning the ability to endure the chemical stress due
to the tissue reaction to implant, a first encouraging result
was the absence of degradation or crack formation on the
pHEMA coated microspheres after their immersion of in a
phosphate buffered saline (PBS) solution containing 30mM of
H2O2 for 1 week, mimicking the situation where the device
is implanted in the human body and hydrogen peroxide is
generated by an inflammatory reaction. The examination of
pHEMA-coated gold microspheres implanted for 1 month in
the rat cortex, finally showed that the hydrogel is not degraded
by the permanence in the brain and is not metabolized as
the fibrin hydrogel used in previous studies (De Faveri et al.,
2014).
Once established that the pHEMA is a viable solution,
we have investigated the quality of recordings by directly
comparing results in acute experiments on rats obtained
with non-encapsulated PEDOT-PSS-CNT coated microspheres.
The absence of significant differences in average SNR ratio
between non-encapsulated and encapsulated PEDOT-PSS-CNT
microspheres proves that the pHEMA hydrogel is suitable for
avoiding the contact of nanomaterials with the brain tissue
without significant adverse effects on the electrode performance.
The next step was the validation of the pHEMA encapsulation
in chronic implants. The comparative behavior of pHEMA
encapsulated and non-encapsulated PEDOT-PSS-CNT
microspheres implanted in the same animal and characterized
by acquiring in vivo impedance spectra shows a similar
trend after 1, 7, 14, 21, and 28 days. During the same time
interval, both electrodes efficiently maintained their ability
to capture action potentials. Recent results have shown that
PEDOT-PSS-CNT coatings improve chronic spike recording
stability (Kozai et al., 2015) and our preliminary data indicates
that the pHEMA encapsulation does not interfere with
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these PEDOT-PSS-CNT properties and stably insulates
the nanomaterial from the tissue even after a prolonged
implant.
Immunofluorescence revealed that implant of the
microsphere microelectrodes produces at 2 and 4 weeks a
contained glial response. In particular, the activated astrocytes
present an extension of their processes smaller than 150 µm
around the electrode track and a more compact mesh in the
proximity of the track thick about 20 µm, also pointed out
by an increase of cell nuclei revealed by DAPI staining. At
4 weeks after implant the pHEMA encapsulation produces
an increase of glia response, as shown by GFAP expression.
Moreover, after implant, only a few activated microglia, the
other major glial cells involved in the inflammatory response, are
evident at 2 weeks in the proximity of the tracks. These limited
manifestations of inflammatory process are not paralleled by
neuron loss around the tracks, as revealed by the presence of
nuclear fluorescence and testified by the capability of both type
of electrodes to record neural activity up to 28 days after the
implant.
Overall, our results indicate that the goal of shielding from
the tissue the PEDOT-PSS-CNT nanomaterial to minimize the
possibility that detached CNTs are shed from the coating inside
the tissue is fullymet by the pHEMA encapsulation, thus bringing
the use of the high performance nanocomposite one step closer
to clinical applications.
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